Genomic Surveillance of Respiratory Syncytial Virus (RSV) during 2023/2024 Nirsevimab prophylaxis, Eastern Spain, early results.
Mengual-Chuliá B, Launes C, Cazorla E, López-Lacort M, Muñoz-Quiles C, Mira-Iglesias A, Agüera M, Penela-Sánchez D, Garcés-Sánchez M, Fernández-García C, Cervera H, Carballido-Fernández M, Pineda-Caplliure A, Mollar-Maseres J, Shalabi-Benavent M, Sanz-Herrero F, Díez-Domingo J, Muñoz-Almagro C, Orrico-Sánchez A, López-Labrador FX; MEDIPRIM and VAHNSI networks; MEDIPRIM network and collaborators; VAHNSI network and collaborators.
Mengual-Chuliá B, et al.
Clin Microbiol Infect. 2026 Apr 11:S1198-743X(26)00186-2. doi: 10.1016/j.cmi.2026.04.003. Online ahead of print.
Clin Microbiol Infect. 2026.
PMID: 41974354